New Drugs

Fam-Trastuzumab Deruxtecan (Enhertu) for HER 2 Amplified Gastric Adenocarcinoma

Post published:March 29, 2022

Christina Bartholomew | Dec 13, 2021 10:46:21 AM Although treatment strategies for patients with metastatic gastric cancer who have failed prior lines of therapy remain limited, novel agents such as trastuzumab…

Mobocertinib, a First-In-Class Oral Therapy for EGFR Exon 20 Insertion-Positive NSCLC

Post published:March 29, 2022

Christian Watts Pharm.D., MSHI Candidate, Larry Buie Pharm.D., BCOP, FCCP, FASHP, Beth Sandy, MSN, CRNP | Dec 13, 2021 12:27:20 PM Introduction: Epidermal growth factor receptor (EGFR) in non-small cell lung cancer…

Go to the previous page
1
2